Dr. Dasilva discusses the evolving management of generalized pustular psoriasis (GPP), highlighting the impact of targeted interleukin (IL)-36 receptor inhibition...
Alexa Hetzel, PA-C, discusses the clinical efficacy of a non-steroidal topical JAK inhibitor that helps patients with vitiligo achieve significant...
Tina Bhutani, MD, MAS, FAAD, discusses new data presented at the 2026 American Academy of Dermatology annual meeting for the...
Walter J. Liszewski, MD, an associate professor of dermatology at Northwestern University, discusses mechanisms of action to consider for treatment...
Raj Chovatiya, MD, PhD, MSCI, an associate professor at Rosalind Franklin University of Medicine and Science Chicago Medical School and...
Harrison Nguyen, MD, MBA, MPH, FAAD, the managing director of Harrison Dermatology and Research Group and clinical assistant professor of...
David Seiter, FNP-C, shares a patient success story involving a teenage patient with severe atopic dermatitis that achieved complete skin...
Fabrizio Galimberti, MD, PhD: The Importance of Targeted Therapy for GPP Treatment
James Del Rosso, DO: JCAD June 2026 Issue Highlights
Tina Bhutani, MD, MAS, FAAD: Use of Spesolimab for Generalized Pustular Psoriasis
James Del Rosso, DO: JCAD May 2026 Issue Highlights
Bruce Strober, MD, PhD, FAAD: Providing Care With Risankizumab in Psoriasis
